Methylprednisolone Terminated Phase 2 Trials for Relapsing Remitting Multiple Sclerosis (RRMS) Treatment

IndicationsStatusPurposePhase
TerminatedTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT03387046A Pilot Study in Participants With Relapsing Remitting Multiple Sclerosis (RR-MS)